Literature DB >> 16014972

Identification of two new HLA-A*1101-restricted tax epitopes recognized by cytotoxic T lymphocytes in an adult T-cell leukemia patient after hematopoietic stem cell transplantation.

Nanae Harashima1, Ryuji Tanosaki, Yukiko Shimizu, Kiyoshi Kurihara, Takao Masuda, Jun Okamura, Mari Kannagi.   

Abstract

We previously reported that Tax-specific CD8(+) cytotoxic T lymphocytes (CTLs), directed to single epitopes restricted by HLA-A2 or A24, expanded in vitro and in vivo in peripheral blood mononuclear cells (PBMC) from some adult T-cell leukemia (ATL) patients after but not before allogeneic hematopoietic stem cell transplantation (HSCT). Here, we demonstrated similar Tax-specific CTL expansion in PBMC from another post-HSCT ATL patient without HLA-A2 or A24, whose CTLs equally recognized two newly identified epitopes, Tax88-96 and Tax272-280, restricted by HLA-A11, suggesting that these immunodominant Tax epitopes are present in the ATL patient in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014972      PMCID: PMC1181560          DOI: 10.1128/JVI.79.15.10088-10092.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

Review 1.  Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism.

Authors:  A Sette; J Sidney
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

Review 2.  Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs.

Authors:  J Sidney; H M Grey; R T Kubo; A Sette
Journal:  Immunol Today       Date:  1996-06

3.  Adult T-cell leukemia: clinical and hematologic features of 16 cases.

Authors:  T Uchiyama; J Yodoi; K Sagawa; K Takatsuki; H Uchino
Journal:  Blood       Date:  1977-09       Impact factor: 22.113

4.  Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation.

Authors:  A Utsunomiya; Y Miyazaki; Y Takatsuka; S Hanada; K Uozumi; S Yashiki; M Tara; F Kawano; Y Saburi; H Kikuchi; M Hara; H Sao; Y Morishima; Y Kodera; S Sonoda; M Tomonaga
Journal:  Bone Marrow Transplant       Date:  2001-01       Impact factor: 5.483

5.  In vitro induction of cytotoxic T lymphocytes specific for Epstein-Barr virus-transformed cells: kinetics of autologous restimulation.

Authors:  K Sugamura; Y Hinuma
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

6.  Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: peptide-induced T-cell immunity.

Authors:  S Hanabuchi; T Ohashi; Y Koya; H Kato; A Hasegawa; F Takemura; T Masuda; M Kannagi
Journal:  J Natl Cancer Inst       Date:  2001-12-05       Impact factor: 13.506

7.  Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation.

Authors:  Nanae Harashima; Kiyoshi Kurihara; Atae Utsunomiya; Ryuji Tanosaki; Shino Hanabuchi; Masato Masuda; Takashi Ohashi; Fumiyo Fukui; Atsuhiko Hasegawa; Takao Masuda; Yoichi Takaue; Jun Okamura; Mari Kannagi
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

Review 8.  Immunological risks of adult T-cell leukemia at primary HTLV-I infection.

Authors:  Mari Kannagi; Takashi Ohashi; Nanae Harashima; Shino Hanabuchi; Atsuhiko Hasegawa
Journal:  Trends Microbiol       Date:  2004-07       Impact factor: 17.079

9.  Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma.

Authors:  Masahiro Kami; Tamae Hamaki; Shigesaburo Miyakoshi; Naoko Murashige; Yoshinobu Kanda; Ryuji Tanosaki; Yoichi Takaue; Shuichi Taniguchi; Hisamaru Hirai; Keiya Ozawa; Masaharu Kasai
Journal:  Br J Haematol       Date:  2003-01       Impact factor: 6.998

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  11 in total

1.  Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation.

Authors:  Tomohiko Kamimura; Toshihiro Miyamoto; Noriaki Kawano; Akihiko Numata; Yoshikiyo Ito; Yong Chong; Koji Nagafuji; Takanori Teshima; Shin Hayashi; Koichi Akashi
Journal:  Int J Hematol       Date:  2012-04-06       Impact factor: 2.490

2.  Live attenuated VZV vaccination induces antitumor immunity in ATLL patients.

Authors:  Tatsuro Jo; Ritsuko Kubota-Koketsu; Yohei Kaneko; Takahiro Sakai; Kazuhiro Noguchi; Sadaharu Irie; Masatoshi Matsuo; Jun Taguchi; Kuniko Abe; Kazuto Shigematsu
Journal:  Cancer Immunol Immunother       Date:  2022-10-01       Impact factor: 6.630

Review 3.  Immunologic control of human T-cell leukemia virus type I and adult T-cell leukemia.

Authors:  Mari Kannagi
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

Review 4.  Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?

Authors:  E H Phillips; A Hodson; O Hermine; A Bazarbachi; K Cwynarski
Journal:  Bone Marrow Transplant       Date:  2016-09-12       Impact factor: 5.483

5.  In vivo immunogenicity of Tax(11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccine.

Authors:  Divya Sagar; Shet Masih; Todd Schell; Steven Jacobson; Joseph D Comber; Ramila Philip; Brian Wigdahl; Pooja Jain; Zafar K Khan
Journal:  Vaccine       Date:  2014-04-13       Impact factor: 3.641

6.  Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers.

Authors:  Ayako Takamori; Atsuhiko Hasegawa; Atae Utsunomiya; Yasuhiro Maeda; Yoshihisa Yamano; Masato Masuda; Yukiko Shimizu; Yotaro Tamai; Amane Sasada; Na Zeng; Ilseung Choi; Naokuni Uike; Jun Okamura; Toshiki Watanabe; Takao Masuda; Mari Kannagi
Journal:  Retrovirology       Date:  2011-12-07       Impact factor: 4.602

Review 7.  Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.

Authors:  Mari Kannagi; Atsuhiko Hasegawa; Yoshiko Nagano; Shuichi Kimpara; Youko Suehiro
Journal:  Retrovirology       Date:  2019-08-22       Impact factor: 4.602

8.  The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases.

Authors:  Mari Kannagi; Atsuhiko Hasegawa; Ayako Takamori; Shuichi Kinpara; Atae Utsunomiya
Journal:  Front Microbiol       Date:  2012-09-03       Impact factor: 5.640

9.  Is There a Role for HTLV-1-Specific CTL in Adult T-Cell Leukemia/Lymphoma?

Authors:  Aileen G Rowan; Charles R M Bangham
Journal:  Leuk Res Treatment       Date:  2011-11-30

Review 10.  Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy.

Authors:  Mari Kannagi; Atsuhiko Hasegawa; Yoshiko Nagano; Tadafumi Iino; Jun Okamura; Youko Suehiro
Journal:  Cancer Sci       Date:  2019-02-19       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.